Results 241 to 250 of about 84,280 (274)

Somatostatin and Somatostatin-Containing Interneurons—From Plasticity to Pathology

Biomolecules, 2022
Małgorzata Kossut, Monika Liguz-Lecznar, Grzegorz Dobrzański   +2 more
exaly  

The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance

Endocrine Reviews, 2003
Steven W J Lamberts
exaly  

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

Annals of Oncology, 2004
Bertram Wiedenmann, Wouter W de Herder, Guido Rindi   +2 more
exaly  

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy

Modern Pathology, 2007
Maria Pia Brizzi, Gelsomina Mansueto, Mauro Papotti   +2 more
exaly  

Radioimmunoassay of somatostatin

Metabolism, 1978
A, Arimura, G, Lundqvist, J, Rothman, R, Chang, R, Fernandez-Durango, R, Elde, D H, Coy, A V, Schally, C, Meyers   +8 more
openaire   +2 more sources

Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 ‘clinically aggressive’ cases

Annals of Oncology, 2010
Mauro Papotti, Luisella Righi, Marco Volante   +2 more
exaly  

High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25

Regulatory Peptides, 1981
F Esch, Paul Brazeau, P Bohlen
exaly  

Somatostatin: An update

Human Pathology, 1983
C M, Fenoglio, D W, King
openaire   +2 more sources

Somatostatin analogs in the diagnosis and treatment of cancer

Trends in Endocrinology and Metabolism, 2002
Wouter W de Herder, Steven W J Lamberts
exaly  

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma

Annals of Oncology, 2006
Massimo Falconi, Gabriele Capurso, Maria Sofia Cattaruzza   +2 more
exaly